Skip to content

To study the efficasy of Madhuyukta Sharpunkha kalka lepa with Jaloukavcharan in dushta vrana

A Randomized Controlled Clinical Study Of Madhuyukta Sharpunkha Kalka Lepa With Jaloukavacharan In The Management Of Dushta Vrana With Special Reference To Infected Wound. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077484
Enrollment
70
Registered
2024-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S00-T88- Injury, poisoning and certain other consequences of external causes Health Condition 2: T07- Unspecified multiple injuries

Interventions

None listed

Sponsors

Dr Monica santosh Patil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients of age 18-60 will be selected 2)Patients who will give consent for the study. 3)Both Sex 4)Patients with all types of Dushtavranawith maximum history of =2 weeks 5)Patients having clinical features of NijaandAgantuja Vrana i.e.foul smell ,pus discharge,pain,burning sensation and edema will be selected for study. 6)Wound size upto 8cm×8cmwill be selected.

Exclusion criteria

Exclusion criteria: 1.The patient who has underlying bony lesions 2. Patientswith Malignant Ulcer. 3. Tuberculous Ulcer. 4. Lepromatous Ulcer. 5. HIV, HbSAg positive patients. 6. Bleeding disorders. 7. Gangrenous wound. 8.Diabetic Wound will not be selected.

Design outcomes

Primary

MeasureTime frame
1)To compare the effectiveness of Madhuyukta Sharpunkha Lepa (Vranaropak Lepa )and Jaloukavcharan with Metrogyl-P ointment in infected wound. 2)To propose an alternative easily available herbal preparation in the management of Dushtavrana. 3)To assess the treatment duration of Dushta Vrana( Infected wound) using study drug topically. 4)To find out therapeutic measures(Jalaukavacharan) that would be useful in the management of ulcer healing which will be cost effective .Timepoint: 45 days

Secondary

MeasureTime frame
NilTimepoint: Nil

Countries

India

Contacts

Public ContactDr Monica santosh Patil
drmanjushakalmegh75@gmail.com9518390211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026